KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Non-Current Deffered Revenue (2016 - 2025)

Chemed (CHE) has 17 years of Non-Current Deffered Revenue data on record, last reported at $136.1 million in Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 8.02% year-over-year to $136.1 million; the TTM value through Dec 2025 reached $136.1 million, up 8.02%, while the annual FY2025 figure was $136.1 million, 8.02% up from the prior year.
  • Non-Current Deffered Revenue reached $136.1 million in Q4 2025 per CHE's latest filing, up from $132.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $136.1 million in Q4 2025 and bottomed at $89.9 million in Q3 2022.
  • Average Non-Current Deffered Revenue over 5 years is $109.0 million, with a median of $101.8 million recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 33.24% in 2021, then dropped 10.49% in 2022.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $98.6 million in 2021, then decreased by 6.36% to $92.3 million in 2022, then increased by 12.71% to $104.1 million in 2023, then increased by 21.11% to $126.0 million in 2024, then increased by 8.02% to $136.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $136.1 million in Q4 2025, $132.4 million in Q3 2025, and $127.7 million in Q2 2025.